Correlation Between RenovoRx and Anebulo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both RenovoRx and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RenovoRx and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RenovoRx and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on RenovoRx and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RenovoRx with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of RenovoRx and Anebulo Pharmaceuticals.
Diversification Opportunities for RenovoRx and Anebulo Pharmaceuticals
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between RenovoRx and Anebulo is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding RenovoRx and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and RenovoRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RenovoRx are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of RenovoRx i.e., RenovoRx and Anebulo Pharmaceuticals go up and down completely randomly.
Pair Corralation between RenovoRx and Anebulo Pharmaceuticals
Given the investment horizon of 90 days RenovoRx is expected to under-perform the Anebulo Pharmaceuticals. In addition to that, RenovoRx is 1.28 times more volatile than Anebulo Pharmaceuticals. It trades about -0.2 of its total potential returns per unit of risk. Anebulo Pharmaceuticals is currently generating about -0.17 per unit of volatility. If you would invest 150.00 in Anebulo Pharmaceuticals on November 28, 2024 and sell it today you would lose (27.00) from holding Anebulo Pharmaceuticals or give up 18.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
RenovoRx vs. Anebulo Pharmaceuticals
Performance |
| Timeline |
| RenovoRx |
| Anebulo Pharmaceuticals |
RenovoRx and Anebulo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with RenovoRx and Anebulo Pharmaceuticals
The main advantage of trading using opposite RenovoRx and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RenovoRx position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.| RenovoRx vs. Adial Pharmaceuticals | RenovoRx vs. Pasithea Therapeutics Corp | RenovoRx vs. Quoin Pharmaceuticals Ltd | RenovoRx vs. Nutriband |
| Anebulo Pharmaceuticals vs. Adagene | Anebulo Pharmaceuticals vs. Acrivon Therapeutics, Common | Anebulo Pharmaceuticals vs. AnaptysBio | Anebulo Pharmaceuticals vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |